Enhanced potency of prasugrel on protease-activated receptors following bivalirudin treatment for PCI as compared to clopidogrel-Reference-Cited by-同舟云学术

Enhanced potency of prasugrel on protease-activated receptors following bivalirudin treatment for PCI as compared to clopidogrel

Published:2019-05 Issue: Volume:177 Page:59-69
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Kimmelstiel Carey,Stevenson Ryan,Nguyen Nga,Van Doren Layla,Zhang Ping,Perkins James,Kapur Navin K.,Weintraub Andrew,Castaneda Vilma,Kuliopulos Athan,Covic Lidija^ORCID

Funder

Eli Lilly and Company

Publisher

Elsevier BV

Subject

Hematology

Reference36 articles.

1. Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial;O'Shea;JAMA,2001

2. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association task force on practice guidelines;Amsterdam;J. Am. Coll. Cardiol.,2014

3. Clinical development of bivalirudin (Angiox): rationale for thrombin-specific anticoagulation in percutaneous coronary intervention and acute coronary syndromes;Serruys;Int. J. Clin. Pract.,2006

4. Meta-analysis comparing bivalirudin versus heparin monotherapy on ischemic and bleeding outcomes after percutaneous coronary intervention;Bertrand;Am. J. Cardiol.,2012

5. Dichotomous effects of exposure to bivalirudin in patients undergoing percutaneous coronary intervention on protease-activated receptor-mediated platelet activation;Holinstat;J. Thromb. Thrombolysis,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetic considerations in therapy with novel antiplatelet and anticoagulant agents;Pharmacogenetics and Genomics;2024-02-19

2. Inhibitory Effects of P2Y12 Receptor Antagonist on PAR1- and PAR4-AP-Induced Platelet Aggregation in Patients with Stroke or TIA;Journal of Stroke and Cerebrovascular Diseases;2021-03

3. Lipid Receptor GPR31 (G-Protein–Coupled Receptor 31) Regulates Platelet Reactivity and Thrombosis Without Affecting Hemostasis;Arteriosclerosis, Thrombosis, and Vascular Biology;2020-12-03

4. Hereditary Disorders of Cardiovascular Calcification;Arteriosclerosis, Thrombosis, and Vascular Biology;2020-11-12

5. PAR4 activation involves extracellular loop 3 and transmembrane residue Thr153;Blood;2020-11-05